Comprehensive Financial Consultants Institutional, Inc. Eli Lilly & CO Transaction History

Comprehensive Financial Consultants Institutional, Inc.

$259 Million
Q3 2024

A detailed history of Comprehensive Financial Consultants Institutional, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Comprehensive Financial Consultants Institutional, Inc. holds 4,534 shares of LLY stock, worth $3.55 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

4,534

Previous 4,537 0.07%

Holding current value

$3.55 Million

Previous $4.11 Million 2.22%

% of portfolio

1.55%

Previous 1.69%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $2,316 - $2,880	-3 Reduced 0.07%	4,534 $4.02 Million
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $292,847 - $367,252	404 Added 9.77%	4,537 $4.11 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $18,950 - $25,352	-32 Reduced 0.77%	4,133 $3.22 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $17,331 - $20,431	-33 Reduced 0.79%	4,165 $2.43 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $9,128 - $12,585	-21 Reduced 0.5%	4,198 $2.25 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $98,207 - $131,314	-280 Reduced 6.22%	4,219 $1.98 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $6,212 - $7,296	-20 Reduced 0.44%	4,499 $1.55 Million
Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $17,042 - $19,857	-53 Reduced 1.16%	4,519 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $241,927 - $275,701	816 Added 21.73%	4,572 $1.52 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $278 - $327	-1 Reduced 0.03%	3,756 $1.22 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $2,346 - $2,916	10 Added 0.27%	3,757 $1.12 Million
Q4 2021 Mar 10, 2022	BUY	$224.85 - $279.04 $842,512 - $1.05 Million	3,747 New	3,747 $939,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.

Account

Comprehensive Financial Consultants Institutional, Inc. Eli Lilly & CO Transaction History